Antiviral Activities of Glycyrrhizin and Its Modified Compounds against Human Immunodeficiency Virus Type 1 (HIV-1) and Herpes Simplex Virus Type 1 (HSV-1) in Vitro

108Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Chemically modified compounds of glycyrrhizin have been synthesized and evaluated for their inhibitory effect on the replication of human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1). Among them, the 11-deoxo compound having a heteroannular diene structure at the C and D rings proved as active against HIV-1 as glycyrrhizin in MT-4 and MOLT-4 cells. It completely inhibited HIV-1-induced cytopathogenicity in both cell lines at a concentration of 0.16 mM. The compound was also effective against HSV-1 with a 50% inhibitory concentration of 0.5 mm. © 1991, The Pharmaceutical Society of Japan. All rights reserved.

Cite

CITATION STYLE

APA

Hirabayashi, K., Iwata, S., Matsumoto, H., Mori, T., Shigeta, S., Ito, M., & Baba, M. (1991). Antiviral Activities of Glycyrrhizin and Its Modified Compounds against Human Immunodeficiency Virus Type 1 (HIV-1) and Herpes Simplex Virus Type 1 (HSV-1) in Vitro. Chemical and Pharmaceutical Bulletin, 39(1), 112–115. https://doi.org/10.1248/cpb.39.112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free